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Multidrug efflux pumps actively expel a wide range of toxic substrates from the cell and play
a major role in intrinsic and acquired drug resistance. In Gram-negative bacteria, these pumps
form tripartite assemblies that span the cell envelope. However, the in situ structure and
assembly mechanism of multidrug efflux pumps remain unknown. Here we report the in situ
structure of the Escherichia coli AcrAB-TolC multidrug efflux pump obtained by electron cryo-
tomography and subtomogram averaging. The fully assembled efflux pump is observed in a
closed state under conditions of antibiotic challenge and in an open state in the presence of
AcrB inhibitor. We also observe intermediate AcrAB complexes without TolC and discover
that AcrA contacts the peptidoglycan layer of the periplasm. Our data point to a sequential
assembly process in living bacteria, beginning with formation of the AcrAB subcomplex and
suggest domains to target with efflux pump inhibitors.
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W ith the increasing use of antibiotics, multidrug resis-tance in pathogenic bacteria has become a publichealth crisis. The capability of numerous bacterial
species to survive in the presence of antibiotics and toxic com-
pounds is partially conferred by the activity of energy-dependent
efflux pumps1,2. In Gram-negative bacteria, these pumps are
multicomponent assemblies that span the cell envelope and are
driven by a primary or a secondary transport component located
in the inner membrane3. AcrAB–TolC is one of the tripartite
pumps that are constitutively expressed in Escherichia coli
(E. coli)4,5. As the main multidrug efflux machinery, AcrAB–TolC
is comprised of the outer membrane protein TolC, the peri-
plasmic adaptor protein AcrA, and the inner membrane trans-
porter AcrB from the resistance-nodulation-cell division (RND)
superfamily3. The AcrAB–TolC efflux pump transports diverse
compounds, conferring resistance to a broad spectrum of anti-
biotics6. Structural studies of this pump have been limited to
individual components by X-ray crystallography7–14 or fully
assembled pumps by cryo-electron microscopy (cryo-EM) single-
particle analysis15–19. These approaches revealed structures
in vitro, but the in situ structure of this pump remains unknown.
Due to the dynamic nature of the three components and their low
binding affinities, it is particularly challenging to capture the
intermediate states of the AcrAB–TolC pump in vitro, and there
is only limited information about the assembly mechanism of the
pump in living cells. Here, we visualize the in situ structure of E.
coli AcrAB–TolC efflux pump by employing cellular electron
cryo-tomography (cryo-ET) and subtomogram averaging. Our
results reveal in situ structures of the fully assembled pump and
its intermediate assembly state and suggest an assembly
mechanism for tripartite efflux pumps in Gram-negative bacteria.
Results
Visualization of AcrAB–TolC pump in E. coli cell envelope. To
enrich AcrAB–TolC pumps in situ, we overexpressed AcrA, AcrB,
and TolC in BL21 (DE3) cells at a level at which the cells can still
replicate and grow (Supplementary Fig. 1). Then we imaged cells
with Cryo-ET under antibiotic treatment that promotes pump
assembly20. Three-dimensional tomographic reconstructions
revealed detailed structures of the Gram-negative bacterial
envelope, with abundant channel-like densities spanning the cell
envelope (Fig. 1 and Supplementary Movie 1). These densities are
rarely observed in wild-type E. coli cells (Supplementary Fig. 2),
implying that they correspond to AcrAB–TolC pumps. In addi-
tion, the distance between the outer membrane and the inner
membrane stays constant at the sites where the AcrAB–TolC
pumps occur, suggesting that the periplasm may be pinched by
these assemblies.
In situ structures of the fully assembled AcrAB–TolC complex.
In order to determine the in situ structure of AcrAB–TolC pump,
we extracted particles of the cell envelope spanning densities and
performed subtomogram averaging. From 1321 subtomograms of
the AcrAB–TolC pump with C3 symmetry, we achieved a
reconstruction at ~15 Å resolution (gold standard FSC, see
"Methods'' section) (Supplementary Figs. 3, 4). The averaged map
resembles the EM structure of the AcrAB–TolC pump, with a
length of ~33 nm (Fig. 2a–c). The in situ arrangement of each
component of the pump matches the previous cryo-EM stu-
dies15–17. The overall architecture of the fully assembled pump
clearly indicates a 3:6:3 ratio for TolC: AcrA: AcrB in situ (Fig. 2b,
c), which agrees with our previous cryo-EM structures16,19.
Notably, the density occupancy in the TolC region is considerably
lower than the rest of the structure, suggesting that TolC may be
absent in a subset of the particles (Supplementary Fig. 5a). We
then performed focused classification with a soft spherical mask
on the upper part of the pump (Supplementary Fig. 5b). This
classification yielded two maps, one showing the full pump with a
visible TolC density, and the other one containing only the
AcrAB subassembly of the pump and the density of the cell
membranes (Supplementary Figs. 5c, 6).
In the fully assembled pump, the inner chamber shows a clear
constriction (Fig. 2a, c), which has only been observed in the apo-
form of an AcrA-AcrB crosslinked pump in previous in vitro
experiments19. Therefore, we concluded that the map corre-
sponded to a closed state and it fitted our higher resolution
published structure (PDB: 5V5S) well. Despite the presence of the
antibiotic, we did not capture the transporting state where a
continuous conduit is formed between TolC and AcrA. However,
our drug resistance test showed that the strain overexpressing the
AcrAB–TolC pumps had a much higher minimum inhibitory
concentration (MIC) than the wild-type strain (Supplementary
Table 1), indicating that the AcrAB–TolC pumps are functional.
Thus, there must be pumps that are in a transporting state in the
bacteria, in order to produce the antibiotic resistance. To validate
that the AcrAB–TolC pumps can open in our system, we treated
the cells with MBX3132, an inhibitor of AcrB, that is known to
lock AcrB of the pump in vitro19. According to our MIC results,
both the wild-type strain and the AcrAB–TolC pump over-
expressing strain became hyper-resistant to puromycin in the
presence of MBX3132 (Supplementary Table 1). Using the same
data collection and processing protocol, we captured the open
state pump that had a continuous conduit through TolC and
AcrA. The structure has a length of 32 nm, shorter than that of
closed state (Fig. 2d and Supplementary Fig. 7), consistent with
our in vitro results obtained by cryo-EM19. The data indicate that
contraction along the long axis is part of active transport in vivo.
Taken together, our data suggest that the opening of the pump
and efflux of antibiotics is likely a transient process, with the
majority of the complexes observed at any given time in a closed
state, rather than an active state.
Compared to single-particle cryo-EM, cellular Cryo-ET
provides the capability of visualizing the interactions of a protein
complex with its surroundings. In the tomograms of bacteria
under antibiotic pressure, we found that the density of the PG
layer is situated just above the top of AcrA when the cell envelope
densities are overlaid with the averaged map of the full pump
(Fig. 2e). These observations suggest that the PG is contacted
both by the coiled-coils of TolC and the α-hairpin loop of AcrA,
instead of the equatorial domain of TolC as previously
proposed21. These interactions are validated by the mask-free
subtomogram average of the same particles (Supplementary
Fig. 8). In addition, our in vivo crosslinking experiment mapped
the binding sites of both AcrA and TolC with PG (Supplementary
Figs. 9, 10), further verifying our observation that both AcrA and
TolC interact with PG in the complex.
In situ structure of the AcrAB subcomplex. As mentioned
above, the three-dimension classification of subtomograms
revealed ~38% of the particles within the dataset do not have
TolC located in the outer membrane (see "Methods'' section). The
averaged density map of these particles represents a bipartite
AcrAB subcomplex (Fig. 3a–c), in which the quaternary organi-
zation of AcrA and AcrB is similar to a proposed assembly model
based on the crystal structure of the recombinant heavy-metal
efflux pump CusBA22. In the structure of AcrAB subcomplex, six
protruding densities of AcrA in the averaged map indicate a 6:3
ratio between AcrA and AcrB, the same as the fully assembled
pump (Supplementary Fig. 5c). The interior of AcrA viewed in a
cross-section through the averaged map of the subcomplex differs
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from that of the fully assembled pump, with the chamber inside
AcrA being smaller (Fig. 3c) and the AcrA hairpin domains not
forming a complete ring structure (Supplementary Fig. 5c). The
helical hairpin region of AcrA repacks to form an alpha-helical
barrel in the transition from the apo to the ligand-bound states of
the AcrAB–TolC assembly, and the reorganization of the AcrA
hexamer is likely to be a critical step for the opening of the TolC
channel to form the active tripartite pump complex19.
In the unmasked average, the tip of AcrA density merges into
the density of PG layer, while the space between the PG and the
outer membrane is empty (Fig. 3d). The PG layer possibly serves
as an anchor to hold the AcrA hexamer in the periplasm to
maintain the stability of AcrAB subcomplex in the envelope or to
help the bipartite AcrAB subcomplex recruit TolC. Our finding
that the AcrAB subcomplex exists as a stable entity in cells is
supported by previous experiments both in vivo and
in vitro20,23,24. We did not observe any complex directly between
AcrB and TolC, which is consistent with prior structural
studies15,16,19. Likewise, AcrA–TolC complexes were not detected
in cells either.
Discussion
In conclusion, we suggest that the pump assembly process follows
a sequential order. Based on the tomography results and data
from in vivo interactions, it is likely that AcrB and AcrA can
associate to form a bipartite complex. The contact between the α-
hairpin domain of AcrA and PG helps to position and maintain
the stability of the AcrAB complex in the cell envelope, and may
permit the subcomplex to walk along the layer until it encounters
TolC (Fig. 4). In the presence of antibiotics, the AcrAB sub-
complex changes its conformation to recruit TolC, which remains
closed in the outer membrane to keep the periplasm isolated from
the extracellular environment. Notably, the in situ fully assembled
closed state pump showed a constriction in between TolC and
AcrA. Next, the pump briefly adopts an open conformation
accompanied with a contraction to promote the expulsion of the
substrate through the chamber and closes immediately after the
drug molecule is expelled.
In this study, we captured the fully assembled pumps on E. coli
membranes exhibiting a closed state in the presence of antibiotics
and an open state in the presence of the AcrB inhibitor. In
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Fig. 1 Visualizing the AcrAB–TolC efflux pump in the E. coli cell envelope. a A single slice from a tomogram of E. coli. The condensed materials shown inside
of the cell are inclusion bodies resulting from membrane protein overexpression. b Zoomed inside view of the cell envelope containing the AcrAB–TolC
pump which is indicated by the red rectangle. c Corresponding three-dimensional annotation of b showing the outer membrane (OM; blue), the inner
membrane (IM; blue), peptidoglycan (PG; yellow), and the AcrAB–TolC pump (cyan). d Top view of the cell envelope containing the AcrAB–TolC pumps
which appear as ring-shaped densities (indicated by the red circle)
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contrast, the structures determined from purified samples are
always in an open state in the presence of antibiotic or inhibitor19.
The significant difference between in situ and in vitro structures
suggests that the OM-PG-IM envelope structure in Gram-negative
bacteria and the potential between the two sides of the inner
membrane may be essential for the regulation of drug efflux by
keeping the conformational changes of TolC and AcrA coupled
with the substrate binding of AcrB. In the cellular environment,
AcrA has its N-terminal anchored in the inner membrane and its
α-hairpin contacting PG, communicating between AcrB and TolC
to regulate the closing and opening of the pump. Such association
is disrupted during the purification, resulting in the constantly
open AcrAB–TolC pump. In addition, the observation of AcrAB
subcomplex suggests a critical role of PG in the assembly of the
pump, which is not preserved in the purified system. With this
insight, we propose that interfering with the interactions of AcrA
with the PG or AcrB may interrupt the assembly process and
block the function of the tripartite efflux pumps, suggesting an
approach to therapeutics targeting assembly.
Our results provide the structure of the AcrAB–TolC pump
and its intermediate assembly state in the native cell membrane
environment. This shows the potential of in situ membrane
protein structure determination with Cryo-ET. While single-
particle analysis has shown great success in solving detailed
protein structures, significant efforts are still needed for mem-
brane protein purification, and the resulting structures may not
truly represent their native state. The recent developments in
cryo-ET make it possible to determine 10–20 Å resolution
structures of membrane-embedded molecular machines25,26, and
resolve their compositional and conformational variability in the
native environment.
Methods
Plasmid construction and protein expression. Plasmid pAcBH which carries the
acrAB locus and coexpresses AcrA and His-tagged AcrB was a gift from Dr.
Akihito Yamaguchi (Osaka University, Suita, Japan)27. The tolC gene was first
amplified using primers TolCinf_F: 5′-AAGGAGATATACATATGAAGAAATTG
CTCCCCATTCTTATCGGCC-3′ and TolCFLAGXhoI_R: 5′-GAGCTCGAGTCA
CTTATCGTCGTCATCCTTGTAATCGTTACGGAAAGGGTTATGACCGTTAC
TGGT-3′, and then was amplified again using TolCinf_F and TolCFLAG_inf_R:
5′-TTGAGATCTGCCATATGTCACTTATCGTCGTCATCCTTGTAATCGTTA
CG-3′. The resulting DNA fragment of tolC-FLAG was cloned into the pRSFDuet-1
plasmid using the In-Fusion cloning method, yielding pRSFDuet-tolC. E. coli BL21
(DE3) cells (Invitrogen) were co-transformed with plasmids pAcBH and
pRSFDuet-tolC to overexpress AcrAB–TolC pump. Cells were cultured in 2xYT
medium with 100 μg/ml ampicillin and 50 μg/ml kanamycin at 37 °C until an
OD600 of 0.8 was reached and then induced by addition of 0.1 mM isopropyl 1-
thio-β-D-galactopyranoside (IPTG) at 20 °C overnight. Protein expression was
examined by Coomassie blue staining and western blotting analysis.
Minimum inhibitory concentration. Minimum inhibitory concentration (MIC) of
puromycin was measured by the twofold dilution method as described previously
with minor modifications28. Briefly, exponentially growing cultures (OD600 of 0.8)
were inoculated at a density of 104 cells per ml into LB medium containing
appropriate antibiotics in the presence of twofold increasing concentrations of
puromycin. Cell growth was determined visually after incubation at 37 °C for 20 h.
In vivo crosslinking and LC/MS-MS analysis. E. coli strain C43 (DE3) delta
acrAB was co-transformed with plasmid pET20b co-expressing AcrA S273C and
AcrB S258C19 and pRSF-duet co-expressing AcrZ and TolC. The S-> C point
mutations form a stabilizing disulfide bridge between AcrA and AcrB. Cells were
grown in 2xYT medium with 50 μg/ml carbenicillin and 50 μg/ml kanamycin at 37
°C to OD600 of 0.5 and then induced with 1 mM IPTG. After 2 h, cells were
harvested by spinning at 4000×g for 5 min, then resuspended in phosphate buffered
saline (PBS) supplemented with 0.2% wt/vol glucose. In vivo crosslinking of pro-
teins to the peptidoglycan with the bifunctional 3,3′-dithiobis (sulfosuccinimidyl
proprionate) (DTSSP) and isolation of the peptidoglycan with sodium dode-
cylsulfate followed the protocol of Li and Howard29, with modifications. A control
sample was also prepared without crosslinking. The isolated peptidoglycan from
the samples were washed three times with PBS to remove traces of sodium
dodecylsulfate, then incubated in PBS with 2 mg/ml lysozyme for 30 min at 37 °C
to digest the peptidoglycan. The samples were centrifuged at 12,000×g for 10 min
and the supernatants loaded onto a 4–12% gradient denaturing PAGE gel without
reducing agent and stained with Coomassie brilliant blue G. A band at roughly 80
kDa that was not present in the control was excised from the gel, treated with DTT
to reduce the DTSSP and then digested with chymotrypsin and analyzed by LC/
MS-MS by the University of Cambridge Proteomics Facility. TolC was identified
with an emPAI score of 11.1 and AcrA with a score of 10.2. Controls with bovine
serum albumin (BSA) were also analyzed from the same gel, selecting a band that
migrated as a dimer. The crosslinked BSA sample identified 126 peptides that had
reacted with the DTSSP, while the control showed 4 false positives. The location of
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Fig. 2 In situ Cryo-ET structures of the fully assembled AcrAB–TolC complex. a The side-view projection of the subtomogram average of the pump in
presence of antibiotics. b Isosurface rendering of a fitted with high resolution cryo-EM model (PDB: 5V5S). c A slice through b showing a constriction at the
boundary between AcrA and TolC (indicated by the red arrow). d A slice through the density map of the pump in presence of AcrB inhibitor (MBX3132).
e Isosurface rendering of b overlaid with density map of the cell envelope
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the peptide fragments with mass corresponding to reduced DTSSP were mapped
onto the crystal structures of TolC and AcrA and correspond to the equatorial
domain and helical hairpin of TolC and the helical hairpin, lipoyl domain and
membrane proximal domain of AcrA (see Supplementary Figs. 9, 10).
Cryo-ET sample preparation. E. coli cells were harvested and washed by PBS
buffer, then resuspended to an OD600 of 1.0. Cultures were mixed with puromycin
(600 μg/ml) or MBX3132 (1.4 μg/ml) and incubated at 37 °C for half an hour.
Subsequently, cells were mixed with a solution of 10 nm BSA fiducial gold (Aurion)
immediately before freezing in a 1:3 cell solution to BSA gold fiducial. A single 3 μl
droplet of the sample was applied to the freshly glow-discharged, continuous
floating carbon film covered grids (Quantifoil Au R3.5/1, 200 mesh) and plunge
frozen using a Vitrobot Mark IV (FEI). Grids were stored in liquid nitrogen until
required for data collection.
Cryo-ET data collection and 3D reconstructions. The frozen-hydrated samples
were imaged on a JEOL 3200FSC (JEOL) operated at 300 kV using a K2 Summit
direct electron detector camera (GATAN), with a magnification of ×10,000 for
antibiotic treated cells and ×2,000 for MBX3132 treated cells. The pixel size is
calibrated to be 3.366 Å and 2.75 Å, respectively. SerialEM30 was used to collect
low-dose, single-axis tilt series at −3 to −6 μm defocus range with an average
cumulative dose of ~76 e−/Å2 distributed over 33 images and covering an angular
range of −50° to +50°, with an angular increment of 3°. Tilted images were
automatically aligned and reconstructed using EMAN2 software31,32. In total, more
than 70 tomograms were generated to provide a sufficient selection for further
processing. Supplementary Table 2 summarizes the Cryo-ET data analysis and
validation statistics.
Subtomogram averaging and correspondence analysis. Twenty-five high SNR
particles were used for initial model generation. A two-step approach was used
to build the initial model. First 5 iterations of the EMAN2 initial model gen-
eration routine were performed imposing C1 symmetry. After aligning the
result to the symmetry axis, we performed 5 more iterations with C3 symmetry,
and used the resulting map as the initial model for subtomogram refinement.
Subtomogram averaging was then performed using 1321 particles from 9
tomograms while applying C3 symmetry. This map was then used as the initial
model for the following subtomogram refinement. To focus on the protein
while preserving information from the membrane for improved alignment, a
mask with values ranging from 0.5 to 1 around the pump and 0 to 0.5 covering
a larger cylinder (~270 Å) was used for the iterative subtomogram refinement
(see Supplementary Fig. 11). The refinement is performed in a gold-standard
fashion with all particles split into two subsets and resolution is measured by
the Fourier shell correlation of the density maps from the two subsets. After 3
iteration of subtomogram refinement, a 19 Å resolution averaged structure was
achieved.
As described in the main text, the TolC region in the averaged map has lower
occupancy. For further classification, we used a soft spherical mask covering the
TolC region. Two initial models were generated from the averaged map obtained
from the last step, one with 0.5× intensity value while the other has 1.5× intensity
value inside the mask. The two maps are identical outside the mask. The two maps
were used to seed a focused classification under the spherical mask for 5 iterations,
resulting in two classes of particles and their corresponding density maps (see
Supplementary Fig. 5).
The two classes of particles are then subject to 3 iterations of subtomogram
refinement separately, using their corresponding initial model and the same mask.
The subtomogram refinement is followed by 3 iterations of sub-tilt refinement,
which produced the two structures shown in the figures.
To solve the structure of the pump with inhibitor, 678 particles from 10
tomograms are used for subtomogram averaging. The same initial model from the
previous dataset was filtered to 50 Å and used as the initial model for the
subtomogram averaging. The 21 Å structure shown in the figure was achieved after
3 iterations of subtomogram refinement.
Visualization and model docking is performed in UCSF Chimera33 and the
built-in fit in map tool.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Data supporting the findings of this manuscript are available from the corresponding
authors upon reasonable request. A reporting summary for this article is available as a
Supplementary Information file. The source data underlying Supplementary Figs 1a is
provided as a Source Data file. Raw data for the chemical cross-links (source data for
Supplementary Fig. 9 and Supplementary Fig. 10) is available via Zenodo data repository
with a DOI (https://doi.org/10.5281/zenodo.2656660). The cryo-ET structure of the
AcrAB subcomplex, AcrAB–TolC close state and AcrAB–TolC open state were deposited
in the EMDB under ID codes EMD-0531, EMD-0532 and EMD-0533, respectively. Raw
cryo-ET data are available from the corresponding author upon reasonable request.
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Fig. 3 In situ Cryo-ET structure of the AcrAB subcomplex. a The side-view
projection of the subtomogram average of the AcrAB subcomplex in
presence of antibiotics. b Isosurface rendering of a fitted with the cryo-EM
single-particle model (PDB: 5V5S). c A slice through the density map of b.
d Isosurface rendering of b overlaid with density map of the cell envelope
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Fig. 4 Proposed in vivo assembly and functioning mechanism for multidrug
efflux pump AcrAB–TolC. First, AcrB associates with AcrA to form the
bipartite complex AcrAB. Next, AcrA changes its conformation to recruit
TolC. Once TolC binds with the AcrAB bipartite complex, the fully
assembled tripartite pump remains in the resting state. When AcrB
encounters a drug molecule, the pump adopts an open conformation
accompanied with a contraction along the long axis and the substrate is
expelled through the channel and out of the cell
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